Acta Med. 2015, 58: 123-127
https://doi.org/10.14712/18059694.2016.3
Dental and Oral Lesions in HIV-Positive Individuals in East Bohemia – Czech Republic, Single Centre Experience
References
1. WHO. Epidemiological fact sheet on HIV/AIDS. UNAIDS 2014. (Internet). UNAIDS; available from: http://www.unaids.org/sites/default/files/en/media/unaids /contentassets/documents/factsheet/2014/20140716_FactSheet_en.pdf
2. WHO gap report epidemiology slides UNAIDS 2014 (Internet). UNAIDS; available from: http://www.unaids.org/en/media/unaids/contentassets/documents /document/2014/2014gapreportslides/01_Epi_slides_2014July.pdf
3. Science 1983; 220: 868–71.
< F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). https://doi.org/10.1126/science.6189183>
4. Science 1984; 224: 497–500.
< M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. https://doi.org/10.1126/science.6200935>
5. Science 1984; 224: 500–3.
< RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS https://doi.org/10.1126/science.6200936>
6. Science 1984; 224: 503–5.
< J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. https://doi.org/10.1126/science.6200937>
7. Science 1984; 224: 506–8.
< MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. https://doi.org/10.1126/science.6324345>
8. Australasian Society for HIV Medicine (ASHM); 2009; 9–17.
J. HIV Management in Australasia a guide for clinical care.
9. SZU. Leden 2014: výskyt a šíření HIV/AIDS v České republice. (Internet); Available from: http://www.szu.cz/uploads/documents/CeM/HIV_AIDS/rocni _zpravy/2014/HIV_AIDS_01_2014.pdf
10. Interim who clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance (Internet). WHO; 2005; available from: http://www.who.int/hiv/pub /guidelines/clinicalstaging.pdf
11. Ann Acad Med Singapore 2004; 33(4 Suppl): 37–42.
K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients.
12. Oral Dis 1997; 3(Suppl 1): 41–5.
< W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. https://doi.org/10.1111/j.1601-0825.1997.tb00372.x>
13. Oral Dis 2006; 12(6): 537–42.
< G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. https://doi.org/10.1111/j.1601-0825.2006.01232.x>
14. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 2002; 31(1): 1–4.
C, Scheifele C, Reichart PA. Oral manifestations in 101 Cambodians with HIV and AIDS.
15. Oral Dis 2008; 14(4): 341–6.
< MA, Ogunbodede EO, Jeboda SO, Naidoo S. Patterns of oral manifestation of HIV/AIDS among 225 Nigerian patients. https://doi.org/10.1111/j.1601-0825.2007.01384.x>
16. Ann Intern Med 1996; 125(6): 485–96.
< M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. https://doi.org/10.7326/0003-4819-125-6-199609150-00010>
17. Mt Sinai J Med N Y 1998; 65(5–6): 322–32.
DA. Oral manifestations of HIV disease.
18. Oral Dis 2005; 11(6): 370–3.
< GA, Wright AA. Oral lesions as indicators of HIV infection among routine dental patients in Lagos, Nigeria. https://doi.org/10.1111/j.1601-0825.2005.01132.x>
19. Int Dent J 2004; 54(3): 131–7.
< A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. https://doi.org/10.1111/j.1875-595X.2004.tb00268.x>
20. Neville B, Damm DD, Allen, CM, Bouquot JE. Oral and Maxillofacial Pathology. 3rd edition. St. Louis: Saunders; 2009.
21. Periodontol 2000 2012; 60(1): 78–97.
< MI, Nittayananta W, Coogan M, Greenspan D, Greenspan JS. Periodontal disease in HIV/AIDS. https://doi.org/10.1111/j.1600-0757.2012.00445.x>
22. Oral Pathol Med. 2013; 42(3): 201–7.
< L, Khammissa RA, Lemmer J, Feller LJ. Oral HIV-associated Kaposi sarcoma. https://doi.org/10.1111/j.1600-0714.2012.01180.x>
23. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 1998; 27(4): 176–9.
TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients.
24. Am J Med 1998; 104(6): 559–64.
< P, Ohmit SE, Sobel JD, Mayer KH, Greene V, Rompalo A, et al. Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. https://doi.org/10.1016/S0002-9343(98)00110-7>
25. SADJ. 2013; 68(8): 364–71.
SR, Wanjau J, Chabikuli N. The prevalence of HIV associated oral lesions among adults in the era of HAART.